JUSTIN MILES: Open Payments
NPI 1881984441 · MINNEAPOLIS, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$191 in 9 payments from 6 companies in 2025. Trend: 2023 $15 · 2024 $69 · 2025 $191
Food & beverage: $191
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 2 | $82 |
| Vanda Pharmaceuticals Inc. | 3 | $42 |
| Lundbeck LLC | 1 | $20 |
| ACADIA Pharmaceuticals Inc | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Janssen Pharmaceuticals, Inc | 1 | $14 |
Products named: Qelbree, FANAPT, REXULTI, NUPLAZID, TRINTELLIX, INVEGA SUSTENNA.
Industry payments across MN — which companies pay providers there.
